Introduction
Kangri cancer represents a unique thermally induced squamous cell carcinoma (SCC) of skin that develops due to chronic irritation by constant exposure to Kangri; the heat pot used to keep body warm during the cold temperatur. [1] [2] [3] The induction of HSP's, occur in wide range of tumors and the mechanism of increased transcription is by either reversal of repression of HSP gene promoter by mutant TP53 (wild type TP53 act as repressor of HSP70 gene) [4] [5] [6] by increased transcription and stabilization of Heat Shock Factor1 {HSF1} [7] and by positive regulation of HSP genes by protooncogenes like c-myc. [8] The 70Kdal HSP70 family includes three intronless genes, Hsp70-1, Hsp70-2, Hsp 70-hom, that have been mapped within the Class III region of MHC complex on 6p21.3. [9, 10] Hsp70-1 and Hsp70-2 genes are 12kb apart and lie 92kb telomeric to C2 gene whileas Hsp70-hom is located 4kb telomeric to Hsp70-1. [9, 10] Hsp70-1 and Hsp70-2 encode identical 641 aminoacid proteins [11] whileas the Hsp70-hom encode a 641 aminoacid protein that shares a 90% sequence identity with other Hsp70 proteins. [12] Genetic polymorphism in HSP70 genes may inß uence its anti-apoptotic and immune modulator function and, therefore, may have consequences on predisposition to and prognosis of the disease. This work Kangri cancer is a unique thermally-induced squamous cell carcinoma (SCC) of skin that develops due to persistent use of Kangri (a brazier), used by Kashmiri people, to combat the chilling cold during winter months. We designed a large scale case-control study to characterize the frequency of two polymorphisms within the MHC class III-linked HSP70genes, Hsp70-2 and Hsp70-hom, in order to Þ nd any association of these genotypic variants for predisposition to and clinical outcome of Kangri cancer patients from Kashmir valley in North India. Polymerase Chain Reaction and restriction enzymes were utilized to characterize the frequency of two polymorphisms with in Hsp70-2 and Hsp70-hom genes in 118 Kangri carcinoma cases and 95 healthy controls from the same population of Kashmir. Association of high frequency allelic variants of Hsp70genes with various clinicopathological features of prognostic signiÞ cance was assessed by Chi-square test using SPSS software. In this study, allelic frequency of Hsp70-2 A/G heterozygote (0.87) (P = 0.012) was found to be signiÞ cantly high in Kangri cancer cases compared to control (0.736) with a Relative Risk of 2.45 fold. Conversely, the allelic frequency of Hsp70-2 A/A allele in homozygous condition was signiÞ cantly low in Kangri cancer cases and worked out to be 0.084 (Vs 0.252 in control) with P is equal to 0.001, implicating it as a protective allele against Kangri cancer in subjects with this genotype. Similarly, signiÞ cantly high frequency of 0.50 (Vs 0.29 in control) of Hsp70-homC/C allele was found in homozygous condition in Kangri cancer cases suggestive of a positive relative risk associated with this genotype (RR is equal to 2.47) (P is equal to 0.002). The overall allele frequency data analysis of Hsp70-2 and Hsp70-hom genes was signiÞ cant (χ 2 is equal to 12.38, P is equal to 0.002; and χ 2 is equal to 12.21, P is equal to 0.002). The study also reveals considerable association of high frequency alleles of HSP70 genes, especially of Hsp70-2 A/G or G/G in Kangri tumors with clinico-pathological features of poor prognosis. These results indicate that the relative risk of Kangri cancer associated with Hsp70-2 and Hsp70-hom gene polymorphisms is conÞ ned to Hsp70-2 A/G or G/G and Hsp70homC/C haplotype in our population. The study, therefore, suggests Hsp70-2 A/G or G/G and Hsp70homC/C genotypes as potential susceptibility markers and independent prognostic indicators in Kangri is a case-control study to investigate a potential association of genetic variation of Hsp70-2 and Hsp70-hom genes with the risk to and prognosis of disease (disease outcome) in a cohort of Kangri cancer cases from Kashmir, North India.
Our data indicate that genetic polymorphism in Hsp70-2 and Hsp70-hom genes may represent susceptibility and prognostic indicators.
Materials and Methods

Patients and controls
The gene and allele frequencies of the Hsp70-2 and Hsp70-hom genes were determined in a group of 95 control subjects and 118 patients with Kangri cancer. 
DNA extraction
Genomic DNA was extracted from peripheral blood leukocytes by standard procedure. About 5 ml of heparinised blood was mixed with 15 ml of DNA lysis solution (155 mM NH 4 Cl, 10 ml KHCO 3 ,0.1 mM EDTA; PH 8.0). Leucocytes were spun down; suspended in 10 ml of saline EDTA solution (75 mM NaCl, 20 mM EDTA PH 8.0),1 ml of 10% SDS, and incubated with proteinase K at 37°C in a water bath overnight. DNA was subsequently separated from proteins by phenol chloroform iso-amyl alcohol procedure. DNA in the supernatant ß uid was precipitated with ethanol and the pellet was dissolved in 400 µl of DNA storage buffer and stored at 4°C.
Polymorphism analysis of the Hsp70-2 and Hsp70-hom genes
Polymorphism within Hsp70-2 and Hsp70-hom genes has been characterized by Milner and Campbell (1992) who identiÞ ed a polymorphic Pst1 site at position 1267A greater than G [=1249A greater than G, (GI is equal to Hsp70-hom C/C and Hsp70-homG/G allele respectively.
Statistical analysis
All statistical analysis was performed using S-PLUS soft-ware. Chi-square test was used to test for a signiÞ cant association between Kangri cancer and Hsp70-2 and Hsp70-hom genotypes (allelic frequencies). Relative risk associated with a particular genotype was estimated by the odds ratio formula. [13] Chi-square test was used to [T2(a,b)] (TNM); [14] lymph node status (N 1 Vs N 0 ) and histopathological Grade [Grade I Vs (Grade II)]. [15] The level of signiÞ cance was set at P less than/equalto 0.05.
Results
Polymorphism in Hsp70-2 and Hsp-hom genes as risk factors for Kangri carcin oma (a) HSP70-2 Polymorphism
The genotype frequencies of Hsp70-2 in patients with Kangri cancer and the control group from the population of Kashmir is shown in Table 1 [ Figure 1 ]. Hsp= Heat shock protein; f = genotype frequencies; χ 2 = Chi-square; OR= odds ratio; $ NS= Not signiÞ cant; The Chi-square test was used whether signiÞ cant differences (P-value) in genotype frequencies were observed when patient group was compared with control subject The allelic frequency of Hsp70-hom genotypes in Kangri cancer patients and control group given in Table 2 [ Figure 2] (P ≤ 0.05) and histopathological grade I (P ≤ 0.05) [ Table   3 ], which suggest it rather a very low risk imposing genotypic variant of Hsp70-hom for Kangri cancer.
Discussion
Several studies have shown statistical evidence of association between speciÞ c human leukocyte antigen (HLA) alleles and risk for or protection against various cancers. [16, 17] In the present study we report a strong association between speciÞ c Hsp70-2 and Hsp70-hom allelic variants and risk for or protection against Kangri cancers in Kashmiri population.
Comparison of Hsp70-2 allele frequencies in patients with Kangri cancer and control subjects from same population of Kashmir indicated a signiÞ cant decrease of Hsp= Heat shock protein; f = genotype frequencies; χ 2 = Chi-square; OR= odds ratio; $ NS= Not signiÞ cant; The Chi-square test was used whether signiÞ cant differences (P-value) in genotype frequencies were observed when patient group was compared with control subjects Conversely, a high relative risk was found in Kangri cancer cases that carry Hsp70-2 G allele in heterozygous or homozygous state [ Table 1 ]. Our Þ nding is in agreement with the two separate reports from Tunisia, where also statistically signiÞ cant breast cancer cases carry Hsp70-2 G allele in homozygous state (0.25) (Vs 0.02 in control) (RR =16.3, P = 0.0001 [18] and 0.280 Vs 0.05 in control (RR = 7.12; P is = 0.0001). [19] The Hsp70-2 G allele in homozygous form has been also reported to impart risk in cancers other than Breast like Non-Hodgkins lymphoma (RR = 18.2; P = 0.0001), [18] nasopharyngeal carcinoma (RR = 2.309; P = 0.006) and in diseases other than cancer. [20] [21] [22] Similarly, a striking difference in the frequency of possibly, by affecting the secondary structure of mRNA, its stability and the timing of co-translational folding that alters the substrate or inhibitor binding sites. [23, 24] NcoI Hsp70-hom polymorphism corresponds to Met greater than Thr substitution at amino acid 493, which from a part of peptide binding domain of Hsp70-hom protein. [12] Based on the Hsp-70 structural model, a Met to Thr substitution at amino acid The Chi-square test was used whether signiÞ cant differences (P-value) in genotype frequencies were observed when patient group was compared with control subjects; a Clinical tumor stage: T1 (a,b)= when tumor size ranges from >2 and >5 cm and metastasis to inguinal nodes but no metastasis, T2 (a,b)= tumor of any size, tumor extends to bone, any no of nodes involved and metastasis, 
